|
For the Three Months
Ended December 31, |
For the Year
Ended December 31, | ||||||||||||||
| 2022 | 2021 | 2022 | 2021 | ||||||||||||
| Non-GAAP Net Loss: | |||||||||||||||
| Net loss | $ | (24,424 | ) | $ | (23,907 | ) | $ | (76,009 | ) | $ | (61,381 | ) | |||
| Add (deduct): | |||||||||||||||
| Depreciation and amortization expense(1) | 2,103 | 1,292 | 7,819 | 3,596 | |||||||||||
| Stock-based compensation(2) | 5,124 | 2,648 | 19,172 | 7,395 | |||||||||||
| Amortization of lease intangible | 333 | — | 1,332 | — | |||||||||||
| Amortization of deferred costs on convertible notes | 468 | — | 1,718 | — | |||||||||||
| Unrealized loss on marketable securities | 196 | 1,763 | 1,855 | 2,002 | |||||||||||
| Acquisition and other (3) | 566 | 5,696 | (676 | ) | 5,696 | ||||||||||
| (Gain) loss on sale of property and equipment | (24 | ) | 10 | 47 | 18 | ||||||||||
| Charitable contribution of common stock | — | 1,084 | 2,272 | 2,242 | |||||||||||
| Impairment of assets | 380 | — | 824 | — | |||||||||||
| Restructuring charge | 1,549 | — | 1,549 | — | |||||||||||
| Non-GAAP Net Loss | $ | (13,729 | ) | $ | (11,414 | ) | $ | (40,097 | ) | $ | (40,432 | ) | |||
| Weighted-average number of shares outstanding used to compute Non-GAAP Net Loss per share, basic and diluted | 47,457,139 | 44,995,598 | 47,158,247 | 26,318,349 | |||||||||||
| Non-GAAP EPS, basic and diluted | $ | (0.29 | ) | $ | (0.25 | ) | $ | (0.85 | ) | $ | (1.54 | ) | |||
Xometry Reports Fourth Quarter and Full Year 2022 Results
 |  | More MCAD News
|
|
RELATED NEWS
